Inventor
John A. Lewicki
Inventor
Los Gatos, CA, US
Overview
Patents· 52 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07KPeptides20%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
C12NMicroorganisms or enzymes7%
C07DHeterocyclic compounds6%
A61NElectrotherapy5%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture3%
C07HSugars3%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests2%
PatentTitleYear
9,850,311Compositions and methods for diagnosing and treating cancer20179,732,139'Methods of treating cancer by administering a soluble receptor comprising a human Fc domain and the Fri domain from human frizzled receptor'20179,676,865'Antibodies to a non-ligand binding region of at least two NOTCH receptors'20179,505,832'Method of treating cancer by administering a monoclonal antibody that binds human NOTCH2 and NOTCH3'20169,228,013'Methods of using the FRI domain of human frizzled receptor for inhibiting Wnt signaling in a tumor or tumor cell'20168,980,260'Monoclonal antibody that binds human notch2 and notch3'20158,945,873'Polynucleotides encoding Notch receptor antibodies'20158,784,811'Method of treating cancer using antibodies to a non-ligand binding region of NOTCH1'20148,765,913'Human frizzled (FZD) receptor polypeptides and methods of use thereof for treating cancer and inhibiting growth of tumor cells'20148,652,472'Compositions and methods for diagnosing and treating cancer'20148,425,903'Methods of treatment by administering antibodies to notch receptors'20138,404,237'Antibodies to the NOTCH1 receptor'20138,324,361'Nucleic acid molecules encoding soluble frizzled (FZD) receptors'20128,226,943'Antibodies to notch receptors'20128,206,713'Method of treating cancer using antibodies to a non-ligand binding region of NOTCH2'20127,939,263'Compositions and methods for treating and diagnosing cancer'20117,919,092'Antibodies to notch receptors'20117,833,791'Lactobacilli expressing biologically active polypeptides and uses thereof'20107,754,467'Surface expression of biologically active proteins in bacteria'20107,723,477'Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth'20107,345,045'Pyrido-pyrimidine compounds as medicaments'20087,312,076'Lactobacilli expressing biologically active polypeptides and uses thereof'20077,189,739'Compounds and methods to treat cardiac failure and other disorders'20077,179,458'Lactobacilli expressing biologically active polypeptides and uses thereof'20077,179,790'Brain natriuretic peptide'20076,974,861'Pharmaceutical compositions and methods using natriuretic peptides'20056,903,096'Quinazoline derivatives as medicaments'20056,897,030'Immunoassays for human brain natriuretic peptide'20056,709,855'Methods for detection and use of differentially expressed genes in disease states'20046,589,954'Compounds and methods to treat cardiac failure and other disorders'20036,586,396'Subcutaneous administration of natriuretic peptide'20036,541,477'Inhibitors of p38-a kinase'20036,476,031'Quinazoline derivatives as medicaments'20026,448,257'Compounds and methods to treat cardiac failure and other disorders'20026,410,540'Inhibitors of p38-kinase'20026,340,685'Compounds and methods to treat cardiac failure and other disorders'20026,277,989'Quinazoline derivatives as medicaments'20016,184,226'Quinazoline derivatives as inhibitors of P-38 .alpha.'20016,130,235'Compounds and methods to treat cardiac failure and other disorders'20005,948,761'Recombinant canine brain natriuretic peptide'19995,674,710'Recombinant techniques for production of human brain natriuretic peptide'19975,258,368'Atrial natriuretic/vasodilator peptide compounds'19935,212,286'Atrial Natriuretic/vasodilator peptide compounds'19935,114,923'Recombinant techniques for production of novel natriuretic and vasodilator peptides'19925,047,397'Linear analogs of atrial natriuretic peptides'19914,935,492'Cyclic analogs of atrial natriuretic peptides'19904,804,650'Analogs of atrial natriuretic peptides'19894,764,504'Novel atrial natriuretic/vasodilator polypeptides'19884,757,048'Synthetic analogs of atrial natriuretic peptides'19884,656,253'Monoclonal antibodies against alveolar surfactant protein'19874,562,003'Monoclonal antibodies against alveolar surfactant protein'19854,474,892'Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same'1984Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1984–2007Based in San Jose, CA, US· patent location history
1985–1992Patents assigned to CALIFORNIA BIOTECHNOLOGY INC (4)· patent assignee history
1985–1993Based in Sunnyvale, CA, US· patent location history
1990–2017Based in Los Gatos, CA, US· patent location history
1997–2008Patents assigned to SCIOS INC (19)· patent assignee history
2010–2017Patents assigned to ONCOMED PHARM INC (17)· patent assignee history
2012–2017Patents assigned to GURNEY AUSTIN (5)· patent assignee history
2012–2017Patents assigned to SATYAL SANJEEV (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SCIOS INC | 19 | 1997–2008 |
| ONCOMED PHARM INC | 17 | 2010–2017 |
| GURNEY AUSTIN | 5 | 2012–2017 |
| SATYAL SANJEEV | 5 | 2012–2017 |
| CALIFORNIA BIOTECHNOLOGY INC | 4 | 1985–1992 |
Locations
| Location | Patents | Span |
|---|---|---|
| Los Gatos, California, US | 38 | 1990–2017 |
| San Jose, California, US | 8 | 1984–2007 |
| Sunnyvale, California, US | 6 | 1985–1993 |